Advertisement

Healthcare regulatory, compliance and policy news

Becker’s reports on healthcare fraud enforcement, new CMS and state regulations, and what each changes for billing, licensure and clinical operations.



More in Legal & Regulatory

A new report from the U.S. Commission on Civil Rights reviews the civil rights foundation for language access, including federal laws, healthcare and education requirements, state and local policies, and the practical need for language services. The report, Language Access…

The Colorado Supreme Court issued a preliminary injunction directing Aurora-based Children’s Hospital Colorado to restore gender-affirming care services as the hospital undergoes a Justice Department probe with patient revenue on the line. In a 5-2 decision issued May 18, the…

Attorneys general from 25 states and the District of Columbia have filed a lawsuit against the Trump administration to block an Education Department rule that limits which degree programs qualify for higher federal student loan limits.  The rule — finalized…

From the owner of healthcare software convicted in a $1 billion Medicare scheme, to two Georgia men sentenced for roles in a $522 million scheme, here are 10 healthcare billing fraud cases Becker’s has reported since April 20:  1. A…

The Oregon Health Authority has approved, with conditions, Renton, Wash.-based Providence’s plan to operate its home care joint venture with Compassus in the state, an agency spokesperson confirmed to Becker’s May 18. Providence first announced its joint venture with Compassus,…

A patient with a gun was shot by an off-duty officer May 12 at Methodist Northlake Hospital in Gary, Ind., ABC affiliate WLS reported May 13. The Gary Police Department told Becker’s one man sustained a gunshot wound during a…

A hospital system that is part of Dallas-based Tenet Healthcare is requesting The Leapfrog Group reimburse nearly $10.5 million in legal fees connected to a 2025 lawsuit that questioned the methodology of Leapfrog’s hospital safety grades.  In March, a federal…

The Supreme Court ruled May 14 to allow providers of mifepristone, an FDA-approved abortion drug, to continue shipping the medication as a Louisiana lawsuit returns to an appeals court.  Mifepristone, which is used in a slight majority of U.S. abortions,…

Advertisement